The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathway-Reference-Cited by-同舟云学术

The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathway

Published:2000-02 Issue:9 Volume:19 Page:1206-1214
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

North S,El-Ghissassi F,Pluquet O,Verhaegh G,Hainaut P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1203413.pdf

Reference47 articles.

1. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV and Neckers LM. . 1998 Nature 392: 405–408.

2. Bacus SS, Yarden Y, Oren M, Chin DM, Lyass L, Zelnick CR, Kazarov A, Toyofuku W, Gray-Bablin J, Beerli RR, Hynes NE, Nikiforov M, Haffner R, Gudkov A and Keyomarsi K. . 1996 Oncogene 12: 2535–2547.

3. Bissonnette N and Hunting DJ. . 1998 Oncogene 16: 3461–3469.

4. Calabro-Jones PM, Aguilera JA, Ward JF, Smoluk GD and Fahey RC. . 1988 Cancer Res. 48: 3634–3640.

5. Capizzi RL. . 1996 Eur. J Cancer 32A: Suppl 4 S5–S16.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WR1065 conjugated to thiol-PEG polymers as novel anticancer prodrugs: broad spectrum efficacy, synergism, and drug resistance reversal;Frontiers in Oncology;2023-07-28

2. Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness;Cancer Cell International;2022-12-26

3. Probability Distributions of p53 Mutations and Their Corresponding Shannon Entropies in Different Cancer Cell Types;Trends in Biomathematics: Stability and Oscillations in Environmental, Social, and Biological Models;2022

4. PSMC2 knockdown suppressed tumor progression of skin cutaneous melanoma;Cell Death Discovery;2021-10-29

5. Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway;Bioengineered;2021-01-01